FI960392A0 - Immunomääritys kollageenin tai kollageenifragmenttien osoittamiseksi - Google Patents

Immunomääritys kollageenin tai kollageenifragmenttien osoittamiseksi

Info

Publication number
FI960392A0
FI960392A0 FI960392A FI960392A FI960392A0 FI 960392 A0 FI960392 A0 FI 960392A0 FI 960392 A FI960392 A FI 960392A FI 960392 A FI960392 A FI 960392A FI 960392 A0 FI960392 A0 FI 960392A0
Authority
FI
Finland
Prior art keywords
collagen
immunoassay
fragments
detection
sample
Prior art date
Application number
FI960392A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI960392A (fi
Inventor
Werner Naser
Erasmus Huber
Christoph Seidel
Ulrich Essig
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP1993/002010 external-priority patent/WO1994003813A1/de
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of FI960392A0 publication Critical patent/FI960392A0/fi
Publication of FI960392A publication Critical patent/FI960392A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
FI960392A 1993-07-28 1996-01-29 Immunomääritys kollageenin tai kollageenifragmenttien osoittamiseksi FI960392A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/EP1993/002010 WO1994003813A1 (de) 1992-07-29 1993-07-28 Immunoassay zum nachweis von kollagen oder kollagenfragmenten
PCT/EP1994/000164 WO1995004282A1 (de) 1993-07-28 1994-01-21 Immunoassay zum nachweis von kollagen oder kollagenfragmenten

Publications (2)

Publication Number Publication Date
FI960392A0 true FI960392A0 (fi) 1996-01-29
FI960392A FI960392A (fi) 1996-01-29

Family

ID=8165750

Family Applications (1)

Application Number Title Priority Date Filing Date
FI960392A FI960392A (fi) 1993-07-28 1996-01-29 Immunomääritys kollageenin tai kollageenifragmenttien osoittamiseksi

Country Status (9)

Country Link
EP (1) EP0711415B1 (ja)
JP (1) JP2703116B2 (ja)
AT (1) ATE168779T1 (ja)
CA (1) CA2167496A1 (ja)
DE (1) DE59406512D1 (ja)
DK (1) DK0711415T3 (ja)
ES (1) ES2122231T3 (ja)
FI (1) FI960392A (ja)
WO (1) WO1995004282A1 (ja)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6110689A (en) 1994-01-21 2000-08-29 Osteometer A/S Method of assaying collagen fragments in body fluids, a test kit and means for carrying out the method and use of the method to diagnose the presence of disorders associated with the metabolism of collagen
GB9506050D0 (en) 1995-03-24 1995-05-10 Osteometer A S Assaying collagen fragments in body fluids
EP0787301B1 (en) 1994-10-17 2001-02-14 Osteometer Biotech AS Estimation of the fragmentation pattern of collagen in body fluids and the diagnosis of disorders associated with the metabolism of collagen
US5750647A (en) * 1995-05-19 1998-05-12 Washington Research Foundation Synthetic peptide analogs of NTx
US6107047A (en) * 1996-03-21 2000-08-22 Osteometer Biotech A/S Assaying protein fragments in body fluids
GB9617616D0 (en) 1996-08-22 1996-10-02 Osteometer Biotech As Assaying protein fragments in body fluids
DE69705423T2 (de) 1996-12-09 2002-05-16 Osteometer Biotech As Herlev Sandwichtest zum nachweis von kollagenfragmenten
US6117646A (en) * 1997-09-22 2000-09-12 Osteometer Biotech A/S Assaying protein fragments in body fluids
US6348320B1 (en) 1998-06-19 2002-02-19 Washington Research Foundation Cartilage resorption assays measuring type II collagen fragments
US6916903B2 (en) 1998-06-19 2005-07-12 Washington Research Foundation Collagen type III synthetic peptides for collagen resorption assays
US6255056B1 (en) 1998-06-19 2001-07-03 Washington Research Foundation Cartilage resorption assays
US6602980B1 (en) 1998-06-19 2003-08-05 Washington Research Foundation Collagen type III synthetic peptides for collagen resorption assays
DK1149111T3 (da) * 1999-01-06 2009-12-14 Univ Southern California Fremgangsmåde og sammensætning til inhibering af angiogenese
ES2327812T3 (es) 1999-07-13 2009-11-04 University Of Southern California Nuevos metodos y composiciones para inhibir la angiogenesis utilizando bases antagonistas de mmp-9 y/o integrinas beta-1.
US7365167B2 (en) 2001-11-26 2008-04-29 Cell Matrix, Inc. Humanized collagen antibodies and related methods
US7390885B2 (en) 2001-11-26 2008-06-24 Cell Matrix, Inc. Humanized collagen antibodies and related methods
US7488792B2 (en) 2002-08-28 2009-02-10 Burnham Institute For Medical Research Collagen-binding molecules that selectively home to tumor vasculature and methods of using same
JP2004108914A (ja) * 2002-09-18 2004-04-08 Kudo Norio コラーゲンの測定方法
US7781171B2 (en) 2003-10-15 2010-08-24 Daiichi Pure Chemicals Co., Ltd. Mehod of pretreating sample and immunological assay method using the same
DE602004020372D1 (de) * 2003-10-15 2009-05-14 Sekisui Medical Co Ltd Verfahren zur probenvorbehandlung sowie immunologisches testverfahren unter verwendung davon
CN117561445A (zh) 2021-03-24 2024-02-13 积水医疗株式会社 Ⅰ型胶原c末端肽的免疫学分析方法
WO2024034580A1 (ja) * 2022-08-08 2024-02-15 株式会社先端生命科学研究所 Ｃｅａｃａｍ１を検出する方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3479158D1 (en) * 1983-03-04 1989-08-31 Noctech Ltd Diagnostic agent, a process for its preparation and its use in diagnostic methods
CA1339952C (en) * 1984-10-29 1998-07-14 William J. Knowles Immunoassays for denatured protein analytes, particularly hb alc, and monoclonal antibodies thereto
DE3714634A1 (de) * 1987-05-02 1988-11-17 Hoechst Ag Verfahren zur selektiven immunologischen bestimmung von intaktem prokollagen peptid (typ iii) und prokollagen (typ iii) in koerperfluessigkeiten und mittel zu dessen durchfuehrung
EP0339443B1 (de) * 1988-04-27 1994-12-21 Hoechst Aktiengesellschaft Monoklonaler Antikörper zur selektiven immunologischen Bestimmung von intaktem Prokollagen Peptid (Typ III) und Prokollagen (Typ III) in Körperflüssigkeiten
WO1990008195A1 (en) * 1989-01-13 1990-07-26 President And Fellows Of Harvard College Monoclonal antibody to human type ix collagen
US5081031A (en) * 1989-12-14 1992-01-14 Regents Of The University Of Minnesota Synthetic polypeptide with type iv collagen activity
GB9014220D0 (en) * 1990-06-26 1990-08-15 Farmos Yhtymy Oy Method for the immunlolgical determinition of the carboxyterminal propeptide of type i procollagen
GB9105893D0 (en) * 1991-03-20 1991-05-08 Orion Yhtymae Oy Bone resorption assay based on a peptide liberated during collagen degradation
DE69315989T2 (de) * 1992-01-31 1998-04-23 David Jeston Baylink Aminoterminale prokollagen 1(i) peptide
DE4225038C2 (de) * 1992-07-29 1995-11-30 Boehringer Mannheim Gmbh Herstellung und Verwendung von Antikörpern gegen Kollagen

Also Published As

Publication number Publication date
JPH08509294A (ja) 1996-10-01
WO1995004282A1 (de) 1995-02-09
JP2703116B2 (ja) 1998-01-26
ATE168779T1 (de) 1998-08-15
EP0711415A1 (de) 1996-05-15
CA2167496A1 (en) 1995-02-09
EP0711415B1 (de) 1998-07-22
ES2122231T3 (es) 1998-12-16
FI960392A (fi) 1996-01-29
DK0711415T3 (da) 1999-04-26
DE59406512D1 (de) 1998-08-27

Similar Documents

Publication Publication Date Title
FI960392A0 (fi) Immunomääritys kollageenin tai kollageenifragmenttien osoittamiseksi
DE69228701D1 (de) Fragmente von Prion Proteinen.
LU91087I2 (fr) Advate(Octocog alfa) soustotes ses formes protégées par le brevet de base.
DK532284A (da) Fremgangsmaade til bestemmelse af antigenaktive aminosyresekvenser
ATE177758T1 (de) Synthetische peptide, antikörper dagegen und ihre verwendung
EP2048505A3 (de) Verfahren zur Früherkennung der Serokonversion eines gegen Hepatitis C-Virus gerichteten Antikörpers
ATE225512T1 (de) Abtrennungsverfahren
ATE207205T1 (de) Verfahren zumm assay von endotoxin-konzentration
ATE191792T1 (de) Verfahren zur detektion von hepatitis c
DK0457804T3 (da) M-CSF-monoklonale antistoffer, som genkender en neutraliserende, konformational epitop
ATE120492T1 (de) Fv antikörperfragment-herstellung.
ATE133993T1 (de) Protein-antikrebsmittel
BR9712585A (pt) Processo de colocar em evidência contaminantes microbiológicos vivos em uma amostra de produto para uso alimentìcio
DE59108915D1 (de) Peptide mit für alpha-1-Mikroglobulin charakteristischer antigener Determinante
ES2115750T3 (es) Ensayo de captura de proteinas de union.
ATE228847T1 (de) Inhibitoren von katalytischen antikörpern
DE59709495D1 (de) Antikörper und immunoassay zum Nachweis von MIA
DE3485219D1 (de) Tgf-polypeptide, davon derivierte antigene oligopeptide, davon erhaltene antikoerper.
DE69028561D1 (de) Immunoassay zum Nachweis von Antikörpern gegen HIV
ATE57016T1 (de) Immunologische bestimmungsmethode zum nachweis von fc-teilbinden bakteriellen polypeptiden und/oder entsprechenden antikoerpern.
DE69011879T2 (de) Immuntestverfahren für zelluläres Eiweiss.
KR890009417A (ko) 모노크로날 항체의 제조방법 및 그것의 이용방법
NO982227D0 (no) Urogenitalcarcinom-TPL komplekspeptider og antistoffer derav
DE69119445T2 (de) Analysemethode für infektiöse Pferdeanämie-Viren (EIA-Virus)
DK1295126T3 (da) Immunoanalysesystemer til påvisning af hepatitis C-virusantigen

Legal Events

Date Code Title Description
HC Name/ company changed in application

Owner name: ROCHE DIAGNOSTICS GMBH